Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia M. Nance is active.

Publication


Featured researches published by Patricia M. Nance.


Regulatory Toxicology and Pharmacology | 2012

Human health risks from mercury exposure from broken compact fluorescent lamps (CFLs).

Patricia M. Nance; Jacqueline Patterson; Alison Willis; N. Foronda; Michael Dourson

Human health risk to infants/toddlers and adults was evaluated based on two exposure scenarios from compact fluorescent lamp (CFL) breakage; first in a room with no ventilation and no clean-up, and second in a room with adequate ventilation and clean-up. Concentration data from multiple exposure scenarios tested in a study by Stahler et al. (2008) were compared to human toxicity benchmarks to calculate hazard quotients. For the no clean-up scenario, hazard quotients were generally less than 1, suggesting an unlikely health risk. When the room was ventilated and the broken CFL was cleaned-up, mercury concentrations were generally lower. A review of release scenarios, along with duration-adjusted toxicity benchmarks, indicated that few releases produced levels of concern, but some scenarios resulted in exceedance of risk targets and require further study. Uncertainties in this screening characterization include assumptions about room size, ventilation, age of lamp, the distribution of mercury in the room, and also the choice of the toxicity benchmarks used to develop the hazard quotients.


Regulatory Toxicology and Pharmacology | 2014

Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment

Michael Dourson; John F. Reichard; Patricia M. Nance; Heather Burleigh-Flayer; Ann Parker; Melissa Vincent; Ernest E. McConnell

1,4-Dioxane is found in consumer products and is used as a solvent in manufacturing. Studies in rodents show liver tumors to be consistently reported after chronic oral exposure. However, there were differences in the reporting of non-neoplastic lesions in the livers of rats and mice. In order to clarify these differences, a reread of mouse liver slides from the 1978 NCI bioassay on 1,4-dioxane in drinking water was conducted. This reread clearly identified dose-related non-neoplastic changes in the liver; specifically, a dose-related increase in the hypertrophic response of hepatocytes, followed by necrosis, inflammation and hyperplastic hepatocellular foci. 1,4-Dioxane does not cause point mutations, DNA repair, or initiation. However, it appears to promote tumors and stimulate DNA synthesis. Using EPA Guidelines (2005), the weight of the evidence suggests that 1,4-dioxane causes liver tumors in rats and mice through cytotoxicity followed by regenerative hyperplasia. Specific key events in this mode of action are identified. A Reference Dose (RfD) of 0.05mg/kgday is proposed to protect against regenerative liver hyperplasia based on a benchmark dose (BMD) approach. Based on this RfD, a maximum contaminant level goal of 350μg/L is proposed using a default relative source contribution for water of 20%.


Environment International | 2016

Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study.

Nancy B. Beck; Richard A. Becker; Neeraja K. Erraguntla; William H. Farland; Roberta L. Grant; George M. Gray; Christopher R. Kirman; Judy S. LaKind; R. Jeffrey Lewis; Patricia M. Nance; Lynn H. Pottenger; Susan L. Santos; Stephanie Shirley; Ted W. Simon; Michael Dourson

Single point estimates of human health hazard/toxicity values such as a reference dose (RfD) are generally used in chemical hazard and risk assessment programs for assessing potential risks associated with site- or use-specific exposures. The resulting point estimates are often used by risk managers for regulatory decision-making, including standard setting, determination of emission controls, and mitigation of exposures to chemical substances. Risk managers, as well as stakeholders (interested and affected parties), often have limited information regarding assumptions and uncertainty factors in numerical estimates of both hazards and risks. Further, the use of different approaches for addressing uncertainty, which vary in transparency, can lead to a lack of confidence in the scientific underpinning of regulatory decision-making. The overarching goal of this paper, which was developed from an invited participant workshop, is to offer five approaches for presenting toxicity values in a transparent manner in order to improve the understanding, consideration, and informed use of uncertainty by risk assessors, risk managers, and stakeholders. The five approaches for improving the presentation and communication of uncertainty are described using U.S. Environmental Protection Agencys (EPAs) Integrated Risk Information System (IRIS) as a case study. These approaches will ensure transparency in the documentation, development, and use of toxicity values at EPA, the Agency for Toxic Substances and Disease Registry (ATSDR), and other similar assessment programs in the public and private sector. Further empirical testing will help to inform the approaches that will work best for specific audiences and situations.


Regulatory Toxicology and Pharmacology | 2014

Derivation of an occupational exposure limit for inorganic borates using a weight of evidence approach

Andrew Maier; Melissa Vincent; E. Hack; Patricia M. Nance; W. Ball

Inorganic borates are encountered in many settings worldwide, spurring international efforts to develop exposure guidance (US EPA, 2004; WHO, 2009; ATSDR, 2010) and occupational exposure limits (OEL) (ACGIH, 2005; MAK, 2011). We derived an updated OEL to reflect new data and current international risk assessment frameworks. We assessed toxicity and epidemiology data on inorganic borates to identify relevant adverse effects. International risk assessment frameworks (IPCS, 2005, 2007) were used to evaluate endpoint candidates: reproductive toxicity, developmental toxicity, and sensory irritation. For each endpoint, a preliminary OEL was derived and adjusted based on consideration of toxicokinetics, toxicodynamics, and other uncertainties. Selection of the endpoint point of departures (PODs) is supported by dose-response modeling. Developmental toxicity was the most sensitive systemic effect. An OEL of 1.6mgB/m(3) was estimated for this effect based on a POD of 63mgB/m(3) with an uncertainty factor (UF) of 40. Sensory irritation was considered to be the most sensitive effect for the portal of entry. An OEL of 1.4mgB/m(3) was estimated for this effect based on the identified POD and an UF of 1. An OEL of 1.4mgB/m(3) as an 8-h time-weighted average (TWA) is recommended.


Reference Module in Biomedical Sciences#R##N#Encyclopedia of Toxicology (Third Edition) | 2014

Mode of Action

Lynne T. Haber; Alison Willis; Patricia M. Nance

This article is a revision of the previous edition article by Lynne Haber, volume 3, pp 123–124,


Journal American Water Works Association | 2014

The crude MCHM chemical spill in Charleston, W.Va. (PDF)

Jeffrey S. Rosen; Andrew J. Whelton; Michael J. McGuire; Jennifer L. Clancy; Timothy Bartrand; Andrew Eaton; Jacqueline Patterson; Michael Dourson; Patricia M. Nance; Craig D. Adams


Encyclopedia of Toxicology (Second Edition) | 2005

Reference Dose (RfD)

Patricia M. Nance


Comprehensive Toxicology (Second Edition) | 2010

Assessing Risks to Human Health

Patricia M. Nance; Oliver Kroner; Lynne T. Haber; Michael Dourson


Archive | 2007

The Information Infrastructure of Toxicology

Philip Wexler; Pertti J. Hakkinen; Patricia M. Nance; Ann Parker; Jacqueline Patterson


Encyclopedia of Toxicology (Second Edition) | 2005

Food Quality Protection Act, US

Patricia M. Nance

Collaboration


Dive into the Patricia M. Nance's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ann Parker

University of Cincinnati

View shared research outputs
Top Co-Authors

Avatar

Lynne T. Haber

University of Cincinnati

View shared research outputs
Top Co-Authors

Avatar

Melissa Vincent

University of Cincinnati Academic Health Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Maier

University of Cincinnati

View shared research outputs
Top Co-Authors

Avatar

Christopher R. Kirman

Engineer Research and Development Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

George M. Gray

George Washington University

View shared research outputs
Researchain Logo
Decentralizing Knowledge